Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Clinical practise guideline of the special interest group in allergy of the ÖGDV - Drug provocation testing in the diagnosis of cutaneous drug reactions].
Kränke B, Aberer W, Egger C, Hawranek T, Reider N, Volc-Platzer B, Wöhrl S; Beirat der Arbeitsgruppe Allergologie der Österreichischen Gesellschaft für Dermatologie und Venerologie (ÖGDV). Kränke B, et al. Among authors: reider n. Wien Klin Wochenschr. 2011 Oct;123(19-20):585-91. doi: 10.1007/s00508-011-0037-5. Epub 2011 Sep 2. Wien Klin Wochenschr. 2011. PMID: 21901272 German.
Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective study.
Gasslitter I, Kirsten N, Augustin M, Torz K, Mrowietz U, Eyerich K, Puig L, Hoetzenecker W, Schütz-Bergmayr M, Weger W, Wolf P, Reider N, Ratzinger G, Papageorgiou K, Meier TO, Maul JT, Anzengruber F, Navarini AA. Gasslitter I, et al. Among authors: reider n. Arch Dermatol Res. 2019 Jul;311(5):421-424. doi: 10.1007/s00403-019-01907-y. Epub 2019 Mar 16. Arch Dermatol Res. 2019. PMID: 30879102 Clinical Trial.
β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy.
Sturm GJ, Herzog SA, Aberer W, Alfaya Arias T, Antolín-Amérigo D, Bonadonna P, Boni E, Bożek A, Chełmińska M, Ernst B, Frelih N, Gawlik R, Gelincik A, Hawranek T, Hoetzenecker W, Jiménez Blanco A, Kita K, Kendirlinan R, Košnik M, Laipold K, Lang R, Marchi F, Mauro M, Nittner-Marszalska M, Poziomkowska-Gęsicka I, Pravettoni V, Preziosi D, Quercia O, Reider N, Rosiek-Biegus M, Ruiz-Leon B, Schrautzer C, Serrano P, Sin A, Sin BA, Stoevesandt J, Trautmann A, Vachová M, Arzt-Gradwohl L. Sturm GJ, et al. Among authors: reider n. Allergy. 2021 Jul;76(7):2166-2176. doi: 10.1111/all.14785. Epub 2021 Mar 11. Allergy. 2021. PMID: 33605465 Free PMC article. Clinical Trial.
Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study.
Nguyen VA, Eisendle K, Gruber I, Hugl B, Reider D, Reider N. Nguyen VA, et al. Among authors: reider n, reider d. Rheumatology (Oxford). 2010 Mar;49(3):583-7. doi: 10.1093/rheumatology/kep413. Epub 2009 Dec 29. Rheumatology (Oxford). 2010. PMID: 20040526 Clinical Trial.
Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.
Inzinger M, Wippel-Slupetzky K, Weger W, Richter L, Mlynek A, Fleischander B, Scheurecker C, Sandor N, Mairhofer D, Sator PG, Moser-Oberthaler S, Häring N, Viznerova P, Painsi C, Tanew A, Ponholzer P, Tatarski R, Brenner W, Stingl G, Salmhofer W, Rappersberger K, Klein G, Saxinger W, Auböck J, Kölli C, Trautinger F, Steiner A, Ratzinger G, Strohal R, Riedl E, Lange-Asschenfeldt B, Pehamberger H, Volc-Platzer B, Selhofer S, Legat FJ, Müllegger R, Reider N, Schmuth M, Hintner H, Hofer A, Gruber-Wackernagel A, Aberer W, Quehenberger F, Wolf P. Inzinger M, et al. Among authors: reider n. Acta Derm Venereol. 2016 Feb;96(2):207-12. doi: 10.2340/00015555-2214. Acta Derm Venereol. 2016. PMID: 26271044 Free article.
89 results